Escherichia coli antimicrobial resistance in acute urinary tract infection lower than reported in Dutch national surveillance database
PLOS One · 2025
DOI: 10.1371/journal.pone.0334222 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift PLOS One, 2025. Verfasst von Marjan J Bruins und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Clinical Microbiology and Infectious Diseases, Isala hospital, Zwolle, The Netherlands. Hauptthemen laut MEDLINE: Urinary Tract Infections, Escherichia coli, Anti-Bacterial Agents, Escherichia coli Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ABR Zorgnetwerk.
Abstract (Originalsprache)
Background
General practice patients with an acute urinary tract infection are usually treated empirically. Urine is only cultured if initial therapy fails. This study aimed to assess whether resistance rates of Escherichia coli ( E. coli ) from initial urine samples differ from those observed after treatment failure, and whether current surveillance data used for treatment guidelines may overestimate resistance in first-line care.
Methods
A prospective observational study was conducted from October 2022 to June 2024 at Isala Hospital in Zwolle, the Netherlands, involving patients from two general practices. Patients with suspected acute UTI were included, excluding those with indwelling catheters. Initial urine samples were cultured, and resistance rates for all E. coli strains isolated were compared with data from the Dutch national AMR database ISIS-AR and regional data. Treatment success or failure was evaluated by recording the prescribed antibiotics and follow-up visits within 28 days.
Results
A total of 366 urine samples from 272 patients were analyzed. E. coli was the most common pathogen (82.2%). Resistance rates for E. coli were lower than those reported in national and regional datasets. Empirical treatment success rates were 95% for nitrofurantoin, 90% for fosfomycin, 92% for ciprofloxacin, and 100% for trimethoprim. Repeat cultures were performed in 19 cases due to persistent symptoms.
Conclusion
The study confirms that the Dutch national guideline for empirical UTI treatment in general practice is effective. However, periodic reviews of resistance rates for common uropathogens are recommended to ensure continued guideline validity and promote responsible antibiotic use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Clinical Microbiology and Infectious Diseases, Isala hospital, Zwolle, The Netherlands.
- General Practice Zuyderhart, Zwolle, The Netherlands.
- General Practice Dok Zuid, Zwolle, The Netherlands.
ORCID-Profile: Marjan J Bruins
Förderung
- ABR Zorgnetwerk
Zitieren
APA
Bruins, M. J., Eijkelkamp-Biesterbos, L., Meutstege, A. M., & Dos Santos, C. O. (2025). Escherichia coli antimicrobial resistance in acute urinary tract infection lower than reported in Dutch national surveillance database. PLOS One. https://doi.org/10.1371/journal.pone.0334222
Vancouver
Bruins MJ, Eijkelkamp-Biesterbos L, Meutstege AM, Dos Santos CO. Escherichia coli antimicrobial resistance in acute urinary tract infection lower than reported in Dutch national surveillance database. PLOS One. 2025. doi:10.1371/journal.pone.0334222
BibTeX
@article{Bruins2025,
author = {Bruins, Marjan J and Eijkelkamp-Biesterbos, Linda and Meutstege, Annemiek M and Dos Santos, Claudy Oliveira},
title = {Escherichia coli antimicrobial resistance in acute urinary tract infection lower than reported in Dutch national surveillance database},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0334222}
}
EUVIMED